-IFPRI Rising prices and declining consumption of pulses cause concern in terms of both nutrition and food inflation in India. This paper outlines policy strategies to increase the availability of pulses at affordable prices in India and also points out limitations of some of the most common recommendations for achieving these objectives. There seems to be no option but to increase Domestic production of pulses in India. The global supply of...

-The Hindu Business Line Govt also revises Rabi target upwards to 14.4 million tonnes Bengaluru: Higher acreage, driven by the rebound in monsoon rainfall this year, is seen lifting the country’s pulses production by about 48 per cent in the current kharif season to around 8.22 million tonnes (mt) against 5.54 mt produced in the corresponding season last year, according to the Agriculture Ministry. Production of arhar or tur is seen up by...

-The Hindu The Centre on Monday approved the enhancing of buffer stock of pulses to 20 lakh tonnes so as to stabilise the prices and encourage farmers to scale up production. “The Cabinet Committee on Economic Affairs has approved the proposal of the Department of Consumer Affairs for increasing the buffer stock to 20 lakh tonnes. It will be built through domestic procurement and imports of 10 lakh tonnes each,” an official...

-Hindustan Times (Agencies) The government Monday decided to raise the buffer stock of pulses to 20 lakh tonnes from 8 lakh tonnes to keep prices stable and encourage farmers. The decision was taken at a meeting of the Cabinet Committee on Economic Affairs, chaired by the Prime Minister Narendra Modi. “The Cabinet Committee on Economic Affairs has approved the proposal of Department of Consumer Affairs on enhancing the buffer stock for pulses up...

-Hindustan Times India’s generic drug manufacturers have flooded the market with cheaper medicines to treat hepatitis C after Gilead Sciences Inc’s patent application was rejected in January 2015. Thanks to domestic drugmakers, the world is looking to India to reduce the price of hepatitis C drug further. “By scaling up the production of generic medicines, India is playing a pivotal role globally in reducing the prices of medicines for hepatitis C,” said Henk...